Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
FDA’s rare disease framework aims to ‘stand the test of time’
Although more details of the framework are forthcoming, CBER Director Karim Mikahil said "the vision here is for this to be a true quantum leap."
Marissa Russo
Oct 28, 2026 3:16pm
CBER Director Mikhail feels FDA is ‘getting back to stability’
Oct 21, 2026 8:00am
How NIH’s Kleinstreuer reduces animal tests without ‘backlash’
Oct 6, 2026 8:00am
Merck and Daiichi pull lung cancer filing after FDA pushback
Sep 28, 2026 4:30am
Overton backs vaccines, mifepristone in confirmation hearing
Sep 24, 2026 2:32pm
FDA launches pilot program to speed up sluggish phase 1 trials
Sep 15, 2026 2:09pm